Gabelli Funds LLC Buys New Stake in Mazor Robotics Ltd – (MZOR)

Gabelli Funds LLC bought a new position in shares of Mazor Robotics Ltd – (NASDAQ:MZOR) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 230,043 shares of the medical instruments supplier’s stock, valued at approximately $13,416,000. Gabelli Funds LLC owned about 0.87% of Mazor Robotics at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. NEXT Financial Group Inc purchased a new stake in Mazor Robotics during the 3rd quarter worth approximately $110,000. Centaurus Financial Inc. acquired a new stake in Mazor Robotics during the 2nd quarter valued at approximately $139,000. Tower Research Capital LLC TRC acquired a new stake in Mazor Robotics during the 2nd quarter valued at approximately $203,000. Marshall Wace LLP acquired a new stake in Mazor Robotics during the 2nd quarter valued at approximately $240,000. Finally, Arlington Financial Advisors LLC acquired a new stake in Mazor Robotics during the 2nd quarter valued at approximately $306,000. 21.71% of the stock is currently owned by institutional investors.

Shares of NASDAQ MZOR opened at $58.32 on Friday. Mazor Robotics Ltd – has a 12 month low of $41.60 and a 12 month high of $76.56. The company has a market cap of $1.53 billion, a price-to-earnings ratio of -116.64 and a beta of 1.32.

Several analysts have commented on MZOR shares. Zacks Investment Research cut shares of Mazor Robotics from a “hold” rating to a “sell” rating in a research note on Wednesday, July 18th. Needham & Company LLC restated a “sell” rating on shares of Mazor Robotics in a research note on Thursday, August 2nd. ValuEngine cut shares of Mazor Robotics from a “buy” rating to a “hold” rating in a research note on Tuesday, August 28th. Finally, BidaskClub upgraded shares of Mazor Robotics from a “hold” rating to a “buy” rating in a research note on Saturday, September 22nd. One research analyst has rated the stock with a sell rating, four have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Mazor Robotics presently has a consensus rating of “Hold” and an average target price of $59.90.

WARNING: This article was reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/11/10/gabelli-funds-llc-buys-new-stake-in-mazor-robotics-ltd-mzor.html.

Mazor Robotics Company Profile

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures.

See Also: Growth Stocks, What They Are, What They Are Not

Institutional Ownership by Quarter for Mazor Robotics (NASDAQ:MZOR)

Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply